Creative Biolabs ADC Blog

Menu

Skip to content
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News

Monthly Archives: May 2023

08May/23

Pfizer Invests 43 Billion Dollars to Buy Seagen!

May 8, 2023UncategorizedADC Products, ADC scquisition Eventbioadc

Recently, Pfizer announced that it would buy Seagen for $229 a share in cash, for a total price of about $43 billion. According to the company’s website, Seagen currently has three ADCRead More…

08May/23

Uptake and Potential Toxicity Mechanism of Non-Target-Dependent ADC—III

May 8, 2023UncategorizedADC, ADC toxicitybioadc

Receptor-mediated Uptake Mechanism The target-dependent uptake and toxicity of ADC can also be mediated by different receptors that recognize the Fc (fragment crystallization) region of the IgG part of ADC. The constantRead More…

08May/23

Uptake and Potential Toxicity Mechanism of Non-Target-Dependent ADC—II

May 8, 2023UncategorizedADC, Nonspecific endocytosisbioadc

Nonspecific endocytosis Endocytosis is an important process in cell uptake of nutrients, regulation of transmembrane kinetics, synaptic vesicle recycling, and so on. Endocytosis can also play an important role in the uptakeRead More…

08May/23

Uptake and Potential Toxicity Mechanism of Non-Target-Dependent ADC—I

May 8, 2023UncategorizedNon-Target-Dependent ADC, VC-MMAEbioadc

Linker-Unstable Payload Connection Connector-payload instability can cause the payload to be released prematurely into the bloodstream and lead to ADC miss toxicity. The choice of connectors is one of the main driversRead More…

08May/23

Non-targeted ADC Uptake Matters!

May 8, 2023Uncategorizedantibody-drug conjugatebioadc

So far, a total of 16 ADC drugs have been approved worldwide, and one (trastuzumab duocarmazine) is still in the stage of applying for listing. In recent years, with the significant increaseRead More…

Categories

Recent Posts

  • Targeting Drug-Resistant Breast Cancer with a Novel ADC
  • Aptamer-Drug Conjugates: The Next Frontier in Targeted Cancer Therapy Shows Encouraging Results
  • A New Hope for Cancer Therapy: How ADCs are Redefining Treatment
  • Hyaluronidase-Conjugated Liposomes May Effectively Target Pancreatic Cancer
  • Beyond the Magic Bullet: How Next-Generation Linkers are Rewriting the ADC Playbook

Archives

Contact Us

USA - UK

Copyright © Creative Biolabs ADC Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Home
  • Antibody-drug Conjugates Research
  • Antibody-drug Conjugates Manufacturing
  • News